HistoCore PEGASUS Plus 000000014048858007Recalls & reported problems
Leica Biosystems Nussloch GmbH · The HistoCore PEGASUS Plus is an automated tissue processor specifically designed for fixation, dehydration, infiltration with intermedium and paraffin infiltration of human tissue specimens used for histological medical diagnosis by a pathologist, e.g. for cancer diagnosis. The HistoCore PEGASUS Plus is designed for in vitro diagnostic applications. · Class 1
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 9
- Deaths reported
- 0
- Injuries reported
- 8
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 9 adverse event reports that list this exact device (DI 04049188217769), received between Mar 31, 2023 and Aug 4, 2026 — classified as 8 injuries, 1 malfunction.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (8 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Insufficient Device Problem Information8
- Contamination1
- Improper or Incorrect Procedure or Method1
- Use of Incorrect Control/Treatment Settings1
Patient problems
- Insufficient Information5
- Tissue Breakdown4
- No Clinical Signs, Symptoms or Conditions1
- Unspecified Tissue Injury1
Recent adverse event reports
The 9 most recent of 9 reports, in the reporter's own words as published by the FDA.
InjuryAug 4, 2026Improper or Incorrect Procedure or Method
On (b)(6) 2026, the customer contacted Leica Biosystems and reported "a processing quality issue affecting small tissue specimens, including endoscopic and biopsy samples. During histological quality control, alterations were observed primarily in nuclear definition, which could potentially impact diagnostic evaluation."On (b)(6) 2026, the Leica representative advised "According to the customer, although the affected samples presented processing quality issues that mainly impacted nuclear visibility, all affected cases were reviewed and reported by experienced pathologists. The report also indicates that no re-biopsies were required and that no patient harm was identified."On (b)(6) 2026, the customer advised the impact to patients had been updated and provided the following information "All affected cases required additional tissue sections and repeat H&E staining. The customer confirmed that eight cases could not be reported for hormone receptor evaluation and that one core biopsy could not be diagnosed. A repeat biopsy was performed, and the customer confirmed that the event resulted in delays in patient diagnosis and patient care." Identifiers for the affected patients were req
Patient problems: Insufficient Information
MAUDE report 50132712 ↗MalfunctionApr 17, 2024Contamination; Insufficient Device Problem Information; Contamination; Insufficient Device Problem Information
ON (B)(6) 2024 LEICA BIOSYSTEMS RECEIVED A COMPLAINT ABOUT BAD SAMPLE QUALITY OF TISSUES PROCESSED ON A HISTOCORE PEGASUS PLUS TISSUE PROCESSOR. THE TISSUE SAMPLES HAD BEEN PROCESSED OVER NIGHT ON (B)(6) 2024.
Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions
MAUDE report 19123912 ↗InjuryApr 9, 2024Use of Incorrect Control/Treatment Settings; Insufficient Device Problem Information; Use of Incorrect Control/Treatment Settings; Insufficient Device Problem Information
ON 11 MARCH 2024 LEICA BIOSYSTEMS RECEIVED A COMPLAINT ABOUT A DENSITOMETER ERROR OF THE HISTOCORE PEGASUS PLUS, TISSUE PROCESSOR. ON 25 MARCH 2024 FURTHER INFORMATION WAS RECEIVED THAT SAMPLES THAT HAD BEEN PROCESSED ON THE TISSUE PROCESSOR ON (B)(6) 2024, (B)(6) 2024 AND (B)(6) 2024 WERE NEGATIVELY IMPACTED AND HAD A BURNT APPEARANCE UNDER THE MICROSCOPE.
Patient problems: Insufficient Information; Unspecified Tissue Injury
MAUDE report 19069646 ↗InjuryApr 7, 2024Insufficient Device Problem Information; Insufficient Device Problem Information
ON 08 MARCH 2024, LEICA BIOSYSTEMS RECEIVED A COMPLAINT THAT THE CUSTOMER EXPERIENCED SUBOPTIMAL TISSUE PROCESSING ON THEIR HISTOCORE PEGASUS PLUS, TISSUE PROCESSOR. THE CUSTOMER INFORMED LEICA BIOSYSTEMS, THAT AS A RESULT, 1 TISSUE SAMPLE HAVE NOT BEEN DIAGNOSED.
Patient problems: Insufficient Information
MAUDE report 19056906 ↗InjuryDec 20, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
ON 06 DECEMBER 2023 LEICA BIOSYSTEMS RECEIVED A COMPLAINT THAT THE CUSTOMER EXPERIENCED SUBOPTIMAL TISSUE PROCESSING ON THEIR HISTOCORE PEGASUS PLUS. AS A RESULT, 6 SAMPLES NEEDED TO BE RECOLLECTED.
Patient problems: Insufficient Information
MAUDE report 18363126 ↗InjurySep 15, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
ON (B)(6) 2023 LEICA BIOSYSTEMS RECEIVED A COMPLAINT THAT THE CUSTOMER EXPERIENCED SUBOPTIMAL TISSUE PROCESSING ON THEIR HISTOCORE PEGASUS PLUS. ON (B)(6) 2023 THE CUSTOMER INFORMED LEICA BIOSYSTEMS, THAT AS A RESULT, 1 BREAST CORE BX SAMPLE HAS NOT BEEN FULLY DIAGNOSED.
Patient problems: Tissue Breakdown
MAUDE report 17754382 ↗InjuryAug 18, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
ON 07 AUGUST 2023 LEICA BIOSYSTEMS RECEIVED A COMPLAINT THAT THE CUSTOMER EXPERIENCED SUBOPTIMAL TISSUE PROCESSING ON THEIR HISTOCORE PEGASUS PLUS. AS A RESULT, 22 SAMPLES NEEDED TO BE RECOLLECTED.
Patient problems: Tissue Breakdown
MAUDE report 17572156 ↗InjuryJun 30, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
ON 05 APRIL 2023 LEICA BIOSYSTEMS RECEIVED A COMPLAINT THAT THE CUSTOMER EXPERIENCED SUBOPTIMAL TISSUE PROCESSING ON THEIR HISTOCORE PEGASUS PLUS, TISSUE PROCESSOR. AS A RESULT, 250 CASSETTES WITH TISSUE SAMPLES WERE AFFECTED.
Patient problems: Tissue Breakdown
MAUDE report 17236342 ↗InjuryMar 31, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
ON 21 FEBRUARY 2023 LEICA BIOSYSTEMS RECEIVED A COMPLAINT THAT THE CUSTOMER EXPERIENCED SUBOPTIMAL TISSUE PROCESSING ON THEIR HISTOCORE PEGASUS PLUS. ON 03 MARCH 2023 THE CUSTOMER INFORMED LEICA BIOSYSTEMS, THAT AS A RESULT, 1 TISSUE SKIN SAMPLE HAS NOT BEEN DIAGNOSED.
Patient problems: Tissue Breakdown
MAUDE report 16654404 ↗
Other PROCESSOR, TISSUE, AUTOMATED devices
- HistoCore PELORIS HistoCore PELORIS 3 (100-120V)Leica Biosystems Melbourne Pty Ltd · Processor, Tissue, Automated1 recall28 reports
- HistoCore PEGASUS 000000014048858005Leica Biosystems Nussloch GmbH · PROCESSOR, TISSUE, AUTOMATED1 recall14 reports
- ASP6025 230V/50-60 Hz 000000014049543267Leica Biosystems Nussloch GmbH · PROCESSOR, TISSUE, AUTOMATED10 reports
- Leica ASP300 S - 230-240V 000000014047643514Leica Biosystems Nussloch GmbH · PROCESSOR, TISSUE, AUTOMATED5 reports
- HistoCore PEARL 000000014049350667Leica Biosystems Nussloch GmbH · PROCESSOR, TISSUE, AUTOMATED4 reports
- Leica TP1020 VF/accessories 1491020US02Leica Biosystems Nussloch GmbH · PROCESSOR, TISSUE, AUTOMATED4 reports
- Tissue-Tek VIP® 6 6040Sakura Finetek U.S.A., Inc. · PROCESSOR, TISSUE, AUTOMATED2 reports
- ASP6025 120V/50-60 Hz 000000014049543268Leica Biosystems Nussloch GmbH · PROCESSOR, TISSUE, AUTOMATED1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page